CARLSBAD, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of ...
A new machine learning framework using reduced-channel EEG and variational mode decomposition achieves 92.16% accuracy in ...
To stratify the risk of future epilepsy, physicians have historically used lumbar puncture, neuroimaging, and electroencephalography in these patients. Four predictors of future epilepsy in children ...
A clinical genetic study identifies a novel CACNA1C missense variant linked to familial mesial temporal lobe epilepsy, ...
The emerging field of medical cannabinoids has experienced a breakthrough in epilepsy and seizure disorders. A team led by D. Samba Reddy, Ph.D., RPh, a Regents Professor in the Department of ...
LONDON, Aug. 10, 2021 /PRNewswire/ -- GW Pharmaceuticals ("GW"), a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines and now part of Jazz ...
Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Nearly 70% had reduced seizure frequency and some patients achieved seizure freedom. Improvement was not ...
Epilepsy encompasses a diverse group of disorders characterized by recurrent unprovoked seizures and requires careful evaluation to classify seizure type, identify underlying etiology, and distinguish ...
Patients with focal nonmotor seizures experience a "disproportionate delay to diagnosis" compared with those with focal motor seizures, especially among teens, new research suggests. Retrospective ...
The dramatic and incapacitating nature of seizures is reflected in the word itself, which derives from the Greek "to take hold"—like an invisible force suddenly grasping someone and controlling their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results